Potential antitrust deregulation could foster a more favourable environment for larger M&A deals, though skepticism remains.

This analysis is based on information available up to January 17, 2025, and market conditions may have changed since then. Gain an edge in your investment decisions with InvestingPro’s in-depth ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

Eli Lilly (NYSE: LLY) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk (NVO) stock slipped after ate-stage trial data for a higher-dose version of its popular obesity therapy, ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

IPC Indice de Precios Y Cotizaciones 49,844.00 14.03 0.03% ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,07,102.37 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...